Prostate Specific Membrane Antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to brain

Published on Dec 8, 2019in bioRxiv
· DOI :10.1101/863456
Jayendrakishore Tanjore Ramanathan (UH: University of Helsinki), Suvi Lehtipuro + 8 AuthorsPirjo Laakkonen29
Estimated H-index: 29
(UH: University of Helsinki)
Glioblastomas and brain metastases (BM) of solid tumors are the most common central nervous system neoplasms associated with very unfavorable prognosis. In this study, we report the association of Prostate Specific Membrane Antigen with various clinical parameters in a large cohort of primary and secondary brain tumors. A tissue micro array containing 371 cases of ascending grade gliomas pertaining to astrocytic origin, samples of 52 cases of primary lung carcinomas with matching brain metastases with follow-up time accounting to 10.4 years was evaluated for PSMA expression using immunohistochemistry. In addition, PSMA expression was studied in brain metastases arising from melanomas and breast carcinomas. Neovascular expression of PSMA was evident alongside with high expression in the proliferating microvasculature of glioblastomas when compared to the tumor cell expression. This result corroborated with the results obtained from the in silico (cancer genome databases) analyses. In the matched primary lung cancers and their brain metastases (n = 52), vascular PSMA expression in primary tumors led to significantly accelerated metastatic dissemination to the brain with a tendency towards poor overall survival. Taken together, we report the vascular expression of PSMA in the primary and secondary brain tumors that globally associates with the malignant progression and poor outcome of the patients.
  • References (45)
  • Citations (0)
📖 Papers frequently viewed together
57 Citations
19 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Sawan Kumar Jha (UH: University of Helsinki)H-Index: 7
#2Khushbu Rauniyar (UH: University of Helsinki)H-Index: 2
Last. Michael Jeltsch (UH: University of Helsinki)H-Index: 36
view all 9 authors...
The lymphatic system is composed of networks of vessels that drain fluids from the body’s tissues and filter it back into the blood. Growing these vessels depends on a factor known as VEGF-C, which is released in an inactive form and must be cut by enzymes before it can work. One enzyme that is known to activate the VEGF-C signal when the early embryo is developing is ADAMTS3. If this signal fails to switch on this can result in a condition known as lymphedema – whereby problems in the lymphatic...
1 CitationsSource
#1Damir Vareslija (RCSI: Royal College of Surgeons in Ireland)H-Index: 6
#2Nolan PriedigkeitH-Index: 9
Last. Leonie S. Young (RCSI: Royal College of Surgeons in Ireland)H-Index: 25
view all 29 authors...
7 CitationsSource
1 CitationsSource
#1Isabell Witzel (UHH: University of Hamburg)H-Index: 15
#2Elena Laakmann (UHH: University of Hamburg)H-Index: 4
Last. Volkmar Müller (UHH: University of Hamburg)H-Index: 49
view all 19 authors...
Background: Brain metastases (BMs) have a major impact on life expectancy and quality of life for many breast cancer patients. Knowledge about treatment patterns and outcomes is limited. Methods: We analysed clinical data of 1712 patients diagnosed with BMs from breast cancer between January 2000 and December 2016 at 80 institutions. Results: Median age at diagnosis of BMs was 56 years (22-90 years). About 47.8% (n = 732) of patients had HER2-positive, 21.4% (n = 328) had triple-negative and 30....
4 CitationsSource
#1Federica FranchinoH-Index: 4
#2Roberta RudàH-Index: 25
Last. Riccardo SoffiettiH-Index: 37
view all 3 authors...
Advances in chemotherapy and targeted therapies have improved survival in cancer patients with an increase of the incidence of newly diagnosed brain metastases (BM). Intracranial metastases are symptomatic in 60-70% of patients. MRI with gadolinium is more sensitive than CT and advanced neuroimaging techniques have been increasingly used in the detection, treatment planning, and follow-up of BM. Apart from the morphological analysis, the most effective tool for characterizing BM is immunohistoch...
7 CitationsSource
#1Ralph B. Puchalski (Allen Institute for Brain Science)H-Index: 6
#2Nameeta ShahH-Index: 1
Last. Greg FoltzH-Index: 3
view all 80 authors...
Glioblastoma is an aggressive brain tumor that carries a poor prognosis. The tumor’s molecular and cellular landscapes are complex, and their relationships to histologic features routinely used for diagnosis are unclear. We present the Ivy Glioblastoma Atlas, an anatomically based transcriptional atlas of human glioblastoma that aligns individual histologic features with genomic alterations and gene expression patterns, thus assigning molecular information to the most important morphologic hallm...
31 CitationsSource
#1Masahide Matsuda (University of Tsukuba)H-Index: 12
#2Eiichi Ishikawa (University of Tsukuba)H-Index: 20
Last. Akira Matsumura (University of Tsukuba)H-Index: 33
view all 9 authors...
Tumor angiogenesis has attracted increasing attention because of its potential as a valuable marker in the differential diagnosis of brain tumors as well as a novel therapeutic target. Prostate-specific membrane antigen (PSMA) is expressed by the neovasculature endothelium of some tumors, with little to no expression by the tumor cells or normal vasculature endothelium. The aim of this study was to investigate the potential of PSMA for the evaluation of the tumor neovasculature of various brain ...
4 CitationsSource
#1Jolanta Kunikowska (Medical University of Warsaw)H-Index: 13
Last. Krolicki Leszek (Medical University of Warsaw)H-Index: 1
view all 3 authors...
3 CitationsSource
#1M KasohaH-Index: 1
#2C UngerH-Index: 1
Last. Ingolf Juhasz-BössH-Index: 5
view all 8 authors...
The present study was undertaken to investigate the expression of prostate-specific membrane antigen (PSMA) in normal breast tissues, in cancerous breast tissues and in distant metastases from patients with breast cancer. Immunohistochemical analysis was performed to determine PSMA expression and angiogenic activity using anti-PSMA mAb and anti-CD31 mAb respectively. Immunofluorescence staining was applied to confirm the exact co-localization of PSMA and CD31. We observed different patterns of P...
3 CitationsSource
#1Sridhar Nimmagadda (Johns Hopkins University)H-Index: 26
#2Mrudula Pullambhatla (Johns Hopkins University)H-Index: 18
Last. Martin Gilbert Pomper (Johns Hopkins University)H-Index: 60
view all 11 authors...
3 CitationsSource
Cited By0